MANDIRA NEUPANE: Open Payments
NPI 1245637172 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 4 payments from 4 companies in 2025. Trend: 2023 $492 · 2024 $575 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $143 |
| AKEBIA THERAPEUTICS INC | 1 | $122 |
| Vantive US Healthcare LLC | 1 | $115 |
| SANOFI-AVENTIS U.S. LLC | 1 | $112 |
Products named: TARPEYO, Vafseo, Renal - PD, THYMOGLOBULIN.
Industry payments across HI — which companies pay providers there.
